Tharimmune to Present at the Microcap Conference 2025
Tharimmune (Nasdaq: THAR), a clinical-stage biotechnology company focused on immunology and inflammation therapies, has announced its participation in The Microcap Conference 2025. The event will take place from January 28-30, 2025, at the Borgata Hotel Casino & Spa in Atlantic City, New Jersey.
The company's management team will deliver a corporate presentation on Thursday, January 30, 2025, at 10:00 AM Eastern Time in Studio 4. During the conference, they will engage in one-on-one meetings with institutional and individual investors to discuss recent developments, growth strategy, and investment opportunities. Interested investors can register for the conference through the provided link.
Tharimmune (Nasdaq: THAR), un'azienda biotecnologica in fase clinica focalizzata sulle terapie per l'immunologia e l'infiammazione, ha annunciato la sua partecipazione a The Microcap Conference 2025. L'evento si terrà dal 28 al 30 gennaio 2025, presso il Borgata Hotel Casino & Spa ad Atlantic City, New Jersey.
Il team di gestione dell'azienda presenterà un intervento corporate giovedì 30 gennaio 2025, alle 10:00 AM ora orientale nello Studio 4. Durante la conferenza, parteciperanno a incontri one-to-one con investitori istituzionali e individuali per discutere degli sviluppi recenti, della strategia di crescita e delle opportunità di investimento. Gli investitori interessati possono registrarsi per la conferenza tramite il link fornito.
Tharimmune (Nasdaq: THAR), una compañía biotecnológica en etapa clínica centrada en terapias de inmunología e inflamación, ha anunciado su participación en The Microcap Conference 2025. El evento se llevará a cabo del 28 al 30 de enero de 2025, en el Borgata Hotel Casino & Spa en Atlantic City, Nueva Jersey.
El equipo directivo de la empresa ofrecerá una presentación corporativa el jueves 30 de enero de 2025, a las 10:00 AM hora del este en el Estudio 4. Durante la conferencia, participarán en reuniones uno a uno con inversores institucionales e individuales para discutir desarrollos recientes, estrategia de crecimiento y oportunidades de inversión. Los inversores interesados pueden registrarse para la conferencia a través del enlace proporcionado.
Tharimmune (Nasdaq: THAR)는 면역학 및 염증 치료에 초점을 맞춘 임상 단계의 생명공학 회사로, The Microcap Conference 2025에 참가한다고 발표했습니다. 이 행사는 2025년 1월 28일부터 30일까지 뉴저지 주 애틀랜틱 시티에 위치한 Borgata Hotel Casino & Spa에서 열릴 예정입니다.
회사의 경영진은 2025년 1월 30일 목요일 오전 10시 동부 표준시에 스튜디오 4에서 기업 발표를 진행할 예정입니다. 회의 중에 그들은 최근 개발, 성장 전략 및 투자 기회를 논의하기 위해 기관 및 개인 투자자와 일대일 회의에 참여할 것입니다. 관심 있는 투자자는 제공된 링크를 통해 회의에 등록할 수 있습니다.
Tharimmune (Nasdaq: THAR), une entreprise de biotechnologie en phase clinique spécialisée dans les thérapies d'immunologie et d'inflammation, a annoncé sa participation à The Microcap Conference 2025. L'événement se déroulera du 28 au 30 janvier 2025, au Borgata Hotel Casino & Spa à Atlantic City, dans le New Jersey.
L'équipe de direction de l'entreprise présentera une présentation corporate le jeudi 30 janvier 2025, à 10h00, heure de l'Est dans le Studio 4. Pendant la conférence, ils participeront à des réunions individuelles avec des investisseurs institutionnels et individuels pour discuter des développements récents, de la stratégie de croissance et des opportunités d'investissement. Les investisseurs intéressés peuvent s'inscrire à la conférence via le lien fourni.
Tharimmune (Nasdaq: THAR), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf Immunologie und Entzündungstherapien konzentriert, hat seine Teilnahme an The Microcap Conference 2025 bekannt gegeben. Die Veranstaltung findet vom 28. bis 30. Januar 2025 im Borgata Hotel Casino & Spa in Atlantic City, New Jersey, statt.
Das Management-Team des Unternehmens wird am Donnerstag, den 30. Januar 2025, um 10:00 Uhr Eastern Time im Studio 4 eine Unternehmenspräsentation halten. Während der Konferenz werden sie in Einzelgespräche mit institutionellen und privaten Investoren treten, um aktuelle Entwicklungen, Wachstumsstrategien und Investitionsmöglichkeiten zu besprechen. Interessierte Investoren können sich über den bereitgestellten Link für die Konferenz registrieren.
- None.
- None.
BRIDGEWATER, NJ / ACCESS Newswire / January 27, 2025 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company committed to pioneering therapies in immunology and inflammation, today announced its participation in The Microcap Conference 2025 being held January 28-30, 2025, in Atlantic City, N.J.
Management will deliver a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company's recent developments, growth strategy, and investment opportunities.
Event: The Microcap Conference 2025
Location: Studio 4, Borgata Hotel Casino & Spa
Date: Thursday January 30, 2025
Time: 10:00 AM Eastern Time
Investors interested in meeting with management can register for the conference here.
About Tharimmune
Tharimmune, Inc. is a clinical-stage biotechnology company developing a diverse portfolio of therapeutic candidates in immunology, inflammation and oncology. Its lead clinical asset, TH104, aims to suppress chronic pruritus associated with primary biliary cholangitis (PBC), a rare autoimmune liver disease with no known cure. The expanded pipeline includes TH023, an oral TNF-alpha inhibitor, offering a new approach to treating autoimmune diseases. Tharimmune is also advancing early-stage multi-specific biologics targeting unique epitopes against multiple solid tumors. The company has a license agreement with OmniAb, Inc. to access their antibody discovery technology for targeting specified disease markers. For more information, please visit: www.tharimmune.com.
Contacts
Tharimmune, Inc.
ir@tharimmune.com
Alliance Advisors IR
Tirth T. Patel
tpatel@allianceadvisors.com
212-201-6614
Contact Information
Tirth Patel
Alliance Advisors IR
tpatel@allianceadvisors.com
1-212-201-6614
SOURCE: Tharimmune Inc.
View the original press release on ACCESS Newswire
FAQ
When and where is Tharimmune (THAR) presenting at The Microcap Conference 2025?
What will Tharimmune (THAR) discuss at The Microcap Conference 2025?
How can investors meet with Tharimmune (THAR) management at The Microcap Conference 2025?
What is the duration of The Microcap Conference 2025 where Tharimmune (THAR) is presenting?
